Clinical Trial Update: A Trial With Subcutaneous Immunotherapy (SCIT) in Patients With Rhinoconjunctivitis Sensitized to Olea Europaea and Phleum Pratense [Phase 1]

View source ↗

Summary

Phase 1 trial update for subcutaneous immunotherapy (SCIT) in patients with rhinoconjunctivitis sensitized to olive and Timothy grass; the study sponsored by Ro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinoconjunctivitis

Drugs mentioned

• Subcutaneous immunotherapy (SCIT)

Snippet

Sponsor: Roxall Medicina España S.A | Conditions: Rhinoconjuntivitis | Phase 1 | Status: COMPLETED